Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care